Results 121 to 130 of about 340,092 (249)

Endometrial Hyperplasia; A Letter to the Editor

مجله دانشکده پزشکی اصفهان, 2012
One of the most common abnormalities in the female genital system, especially during the premenopausal period, is abnormal uterine bleeding caused by endometrial hyperplasia. Prevalence of endometrial hyperplasia is 5-20% with different risk factors such
Mansour Moghimi, Hamidreza Soltani, Nsrin Partoei, Elham Soltani   +3 more
doaj  

Before the Burn: Predicting Endometrial Ablation Failure

Australian and New Zealand Journal of Obstetrics and Gynaecology, Volume 66, Issue 1, February 2026.
ABSTRACT Background While endometrial ablation (EA) offers a minimally invasive alternative to a hysterectomy for women suffering from abnormal uterine bleeding (AUB), clinicians currently lack reliable predictive tools to identify which patients will experience treatment failure, leaving both providers and patients to make treatment decisions with ...
Anne Woolfield, Jessica Phillips, Ian Hughes, Kristen Jones, Rhys Harris, Sally Byford, Graeme Walker   +6 more
wiley   +1 more source

Mixed Gonadal Dysgenesis: A Comprehensive Review of Clinical Spectrum, Diagnostic Strategies, and Management Approaches

Clinical Endocrinology, Volume 104, Issue 2, Page 92-102, February 2026.
ABSTRACT Background Mixed gonadal dysgenesis (MGD) is a rare form of differences in sex development (DSD) typically associated with 45,X/46,XY mosaicism. The phenotypic presentation of MGD varies from atypical genitalia to typical male or female appearances often associated with Turner stigmata.
Dinesh Giri, Sushil Yewale, Hannah Hickingbotham, Cara Williams, Mohamed Shalaby, Julie Alderson, Julie Park   +6 more
wiley   +1 more source

RISK FACTORS OF TREATMENT FAILURE AND RECURRENT ENDOMETRIAL HYPERPLASIA IN WOMEN OF REPRODUCTIVE AGE WITH OBESITY

Фундаментальная и клиническая медицина, 2016
Aim: To identify the risk factors for treatment failure and recurrent endometrial hyperplasia in women of reproductive age with obesity. Materials and Methods: We performed a retrospective, case-control study. The study included 92 women
Elena A. Shakirova, Natalia V. Artymuk
doaj  

Pregnancy outcomes in infertile patients with endometrial hyperplasia with or without atypia undergoing in vitro fertilization: the early-follicular long protocol is superior to midluteal long protocol

Frontiers in Endocrinology
BackgroundAlthough in vitro fertilization (IVF) in infertile patients with endometrial hyperplasia is common after drug treatment, the pregnancy outcomes are often unsatisfactory.
Huiling An, Huiling An, Huiling An, Tongjie Li, Tongjie Li, Tongjie Li, Kai Huang, Kai Huang, Kai Huang, Hao Shi, Hao Shi, Hao Shi, Chen Wang, Chen Wang, Chen Wang, Ting Chu, Ting Chu, Ting Chu, Jun Zhai, Jun Zhai, Jun Zhai   +20 more
doaj   +1 more source

ENDOMETRIAL PRECANCER: DEFINITION OF CONCEPTS, TACTICS

Акушерство, гинекология и репродукция, 2016
Objective. To substantiate indications for a differential approach in the treatment of patients with atypical endometrial hyperplasia.Materials and Methods.The results of surgical treatment in 132 patients with atypical endometrial hyperplasia have been ...
Iu. Iu. Tabakman, A. G. Solopova, A. Kh. Bishtavi, L. E. Idrisova   +3 more
doaj   +1 more source

Oral and intrauterine progestogens for atypical endometrial hyperplasia.

Cochrane Database of Systematic Reviews, 2018
BACKGROUND Endometrial carcinoma is the most common gynaecologic malignancy in the world and develops through preliminary stages of endometrial hyperplasia.
Li Luo, B. Luo, Ying Zheng, Heng Zhang, Jing Li, N. Sidell   +5 more
semanticscholar   +1 more source

Loss of B‐cell lymphoma 2 immunohistochemical expression in endometrial hyperplasia: A specific marker of precancer and novel indication for treatment

Acta Obstetricia et Gynecologica Scandinavica, 2018
Endometrial hyperplasia is differentiated into benign or premalignant. Two histological classifications are used for this purpose: World Health Organization (WHO) classification, based on cytological atypia, disregarding glandular complexity, and ...
Antonio Travaglino, A. Raffone, G. Saccone, L. Insabato, A. Mollo, G. De Placido, F. Zullo   +6 more
semanticscholar   +1 more source

Levonorgestrel-releasing intrauterine system for endometrial hyperplasia.

Cochrane Database of Systematic Reviews, 2017
BACKGROUND In the absence of treatment, endometrial hyperplasia (EH) can progress to endometrial cancer, particularly in the presence of histologic nuclear atypia.
T. Mittermeier, Charlotte Farrant, M. Wise   +2 more
semanticscholar   +1 more source

Benefits of Levonorgestrel Intrauterine Device Use vs. Oral or Transdermal Progesterone for Postmenopausal Women Using Estrogen Containing Hormone Therapy

INNOVATIONS in Pharmacy, 2019
Background: Endometrial hyperplasia is a major concern for women that start estrogen replacement therapy (ERT) to control symptoms experienced during perimenopause and postmenopause.
Kaylee Clark, Sarah M. Westberg
doaj   +1 more source